Association of Vitamin D or Calcium Supplementation with Cardiovascular Outcomes and Mortality: A Meta-Analysis with Trial Sequential Analysis

Abstract

Background

To exploring the role of vitamin D or calcium supplementation in reducing all-cause mortality and cardiovascular outcomes.

Methods

The search was restricted to systematic reviews or metaanalyses published from January 1, 2010, to July 7, 2019. An additional search was performed to identify recently published randomized controlled trials (from January 1, 2015, to July 7, 2019). Homogeneous results from different studies were pooled using Revman 5.3 software.

Results

Twenty-three studies involving 89,251 participants were ultimately included in this meta-analysis. No associations were observed between the supplementation and composite cardiovascular outcomes, consisting of all-cause mortality, cardiovascular mortality, myocardial infarction, and other MACEs.

Conclusions

Whether used alone or in combination, vitamin D and calcium supplementation do not exert meaningful effects on all-cause mortality, cardiovascular mortality, MACEs or MI among community-dwelling adults.

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

References

  1. 1.

    Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: an arrative review. Clin Hypertens. 2018; 2018: 24.

    Google Scholar 

  2. 2.

    LM M, FP B, MM J, et al. Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study. ESC Heart Failure. 2016, 2016(3): 3.

    Google Scholar 

  3. 3.

    Cerit L, Ozcem B, Cerit Z, Duygu H. Preventive Effect of Preoperative Vitamin D Supplementation on Postoperative Atrial Fibrillation. Braz J Cardiovasc Surg. 2018, 2018(33): 4.

    Google Scholar 

  4. 4.

    Oberoi D, Mehrotra V, Rawat A. Vitamin D as a profile marker for cardiovascular diseases. Ann Card Anaesth. 2019;22:47–50.

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;2008:117.

    Google Scholar 

  6. 6.

    Rivera-Leon EA, Palmeros-Sanchez B, Llamas-Covarrubias IM, et al. Vitamin-D receptor gene polymorphisms (Taql and Apal) and circulating osteocalcin in type 2 diabetic patients and healthy subjects. Endokrynol Pol. 2015;2015:66.

    Google Scholar 

  7. 7.

    J. Parker O, Hashmi D, Dutton A, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;2010(65):3.

    Google Scholar 

  8. 8.

    K. Kienreich, A. Tomaschitz, N. Verheyen, et al. Vitamin D and cardiovascular disease. Nutrients. 2013;2013(5):8.

    Google Scholar 

  9. 9.

    M. Wacker, M.F. Holick. Vitamin D—effects on skeletal and extra skeletal health and the need for supplementation. Nutrients. 2013;2013(5):1.

    Google Scholar 

  10. 10.

    LeFevre ML, U.S. Preventive Services Task Force. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015; 2015(162): 2.

    Google Scholar 

  11. 11.

    Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary supplement use among US adults from 1999–2012. JAMA. 2016;2016(316):14.

    Google Scholar 

  12. 12.

    P. Pludowski, M.F. Holick, W.B. Grant, et al. Vitamin D supplementation guidelines. J. Steroid Biochem. Mol. Biol. 2018; 2018: 175.

    Google Scholar 

  13. 13.

    Michail Apostolakis, Eleni Armeni, Panagiotis Bakas, Irene Lambrinoudaki. Vitamin D and cardiovascular disease. Maturitas. 2018;115.

  14. 14.

    Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis. JAMA Cardiol. 2019: E1-E14.

  15. 15.

    Manson JE, Cook NR, Leel M, et al; VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Bislev LS, Langagergaard Rodbro L, Bech JN, et al. The effect of vitamin D3 supplementation on markers of cardiovascular health in hyper parathyroid, vitamin D insufficient women: a randomized pi acebo-controlled trial. Endocrine. 2018;2018(62):1.

    Google Scholar 

  17. 17.

    Angellotti E, D’Alessio D, Dawson-Hughes B, et al. Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. Clin Nutr. 2018:1–5.

  18. 18.

    Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Med Res Methodol. 2009; 9:86.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  19. 19.

    G. H. Guyatt, A. D. Oxman, G. E. Vist, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;2008(336):7650.

    Google Scholar 

  20. 20.

    G.H. Guyatt, A.D. Oxman, S. Sultan, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology. 2011;2011(64):12.

    Google Scholar 

  21. 21.

    Malluche HH, Faugere MC, Friedler RM, Fanti P. 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. Endocrinology. 1988;1988(122):5.

    Google Scholar 

  22. 22.

    Ott SM, Chesnut CH III. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med. 1989; 1989(110): 4.

    Google Scholar 

  23. 23.

    Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fracture in elderly women. N Engl J Med. 1992;1992(327):23.

    Google Scholar 

  24. 24.

    Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J. Clin. Endocrinol Metab. 1995;1995(80):4.

    Google Scholar 

  25. 25.

    Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann. Intern. Med. 1996; 1996(124): 4.

    Google Scholar 

  26. 26.

    Baeksgaard L, Andersen KP, Hyldstrup L. Calcium and Vitamin D Supplementation Increases Spinal BMD in Healthy, Postmenopausal Women. Osteoporos Int 1998; 8(3): 255–60.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Komulainen M, Kröger H, Tuppurainen MT, et al. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab. 1999;1999(84):2.

    Google Scholar 

  28. 28.

    Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13(3):257–64.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitaminD3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double-blind controlled trial. BMJ. 2003;2003(326):7387.

    Google Scholar 

  30. 30.

    Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch. Intern. Med. 2006; 2006(166): 8.

    Google Scholar 

  31. 31.

    Reid IR, Mason B, Home A, et al. Randomized controlled trial of calcium in healthy older women. Am. J. Med. 2006;2006(119):9.

    Google Scholar 

  32. 32.

    Hsia J, Heiss G, Ren H, et al. Women’s Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;2007(115):7.

    Google Scholar 

  33. 33.

    Lyons RA, Johansen A, Brophy S, et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitaminD supplementation. Osteoporos Int. 2007;2007(18):6.

    Google Scholar 

  34. 34.

    Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch. Intern. Med. 2008;2008(168):20.

    Google Scholar 

  35. 35.

    Zhu K, Devine A, Dick IM, Wilson SG, Prince RL. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab. 2008;93(3):743–49.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2008; 168(1): 103–8.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;2010(303):18.

    Google Scholar 

  38. 38.

    Chailurkit LO, Saetung S, Hakkinstian A, Ongphiphadhanakul B, Rajatanavin R. Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin. Endocrinol. 2010;2010(73):2.

    Google Scholar 

  39. 39.

    Gallagher JC, Sai A, Templin T, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann. Intern. Med. 2012;2012(156):6.

    Google Scholar 

  40. 40.

    Witham MD, Price RJG, Struthers AD, et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med. 2013; 173(18): 1672–79.

    CAS  PubMed  Google Scholar 

  41. 41.

    Baron JA, Barry EL, Mort LA, et al. A trial of calcium and vitamin D for the prevention of colorectal adenomas. N Engl J Med. 2015;2015(373):16.

    Google Scholar 

  42. 42.

    Scragg R, Stewart AW, Waayer D, et al. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial. JAMA Cardiol. 2017;2017(2):6.

    Google Scholar 

  43. 43.

    Manson JE, Cook NR, Leel M, et al; VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;2019(380):1.

    Google Scholar 

  44. 44.

    Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis. JAMA Cardiol. 2019: E1–E11.

  45. 45.

    Elamin MB, AbuElnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011; 2011(96): 7.

    Google Scholar 

  46. 46.

    Ford JA, MacLennan GS, Avenell A, et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;2014(100):3.

    Google Scholar 

  47. 47.

    LeFevre ML, LeFevre NM. Vitamin D screening and supplementation in community-dwelling adults: common questions and answers. Am Fam Physician. 2018;2018(97):4.

    Google Scholar 

  48. 48.

    Quyyumi AA, Al Mheid I. The Demise of Vitamin D for Cardiovascular prevention. JAMA Cardiol. 2019: E1–E2.

Download references

Funding

Funding: This work was funded by Beijing «Double First-rate» Personnel Department-High-level-Scientific Research funding Project for Wangyong’s team [No. 1000041510165 (18–19)],the Nation Natural Science Foundation of China (No.81822049, 81673712), Fok Ying Tung Education Foundation (No. 151044), Beijing Nova program (Z171100001117028) and the National Key R&D Program of China (No. 2017YFC1700100, 2017YFC1700102). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.

Author information

Affiliations

Authors

Contributions

Contributors: Authors’ contributions: Funding acquisition, Wei Wang and Yong Wang; Methodology, Yili Zhang and Xu Wei; Project administration, Wei Wang and Yong Wang; Resources, Yili Zhang and Nannan Tan; Software, Yuan Li; Visualization, Yili Zhang and Yuan Li; Writing - original draft, Yili Zhang, Yuan Li, Junjie Liu and Xu Wei; Writing - review & editing, Nannan Tan, Jian Zhang, Huihui Zhao and Yong Wang.

Corresponding authors

Correspondence to Wei Wang or Yong Wang.

Ethics declarations

Conflict of Interest: The authors declare that they have no conflict of interest.

Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Li, Y., Liu, J. et al. Association of Vitamin D or Calcium Supplementation with Cardiovascular Outcomes and Mortality: A Meta-Analysis with Trial Sequential Analysis. J Nutr Health Aging 25, 263–270 (2021). https://doi.org/10.1007/s12603-020-1551-9

Download citation

Key words

  • Evidence-based medicine
  • cardiovascular
  • vitamin
  • prevention
  • meta-analysis